GGrantIndex
Sort

11,323 grants matching glioblastoma

Biophysical and molecular dialogue of glioma cells and the brain microenvironment

$929,349
Gabriele Bergers · University Of California, San Francisco · U54 · FY2015 · CA

Quantifying Multiscale Competitive Landscapes of Clonal Diversity in Glioblastoma

$929,069
Kristin R Swanson · Mayo Clinic Arizona · U01 · FY2018 · CA

Targeting off-the-shelf iPSC-derived natural killer cells against solid tumors

$928,524
Jeffrey S Miller · University Of Minnesota · R35 · FY2023 · CA

Targeting off-the-shelf iPSC-derived natural killer cells against solid tumors

$928,524
Jeffrey S Miller · University Of Minnesota · R35 · FY2025 · CA

Sex-based Differences in Glioma

$926,753
Justin D. Lathia · Cleveland Clinic Lerner Com-Cwru · P01 · FY2021 · CA

Regulation of Differentiation of Pediatric Embryonal Tumors- Neuroblastoma

$926,748
Carol Thiele-Galetto · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA

Elucidating and Targeting tumor dependencies and drug resistance determinants at the single cell level

$925,687
Andrea Califano · Columbia University Health Sciences · U01 · FY2024 · CA

Development of Small Molecule Inhibitors and Biologic Agents for Treatment of Glioblastoma Using Intracerebral Microdialysis and Signatures of Vulnerability

$925,385
Jana Portnow · Beckman Research Institute/City Of Hope · U19 · FY2025 · CA

Towards a quantitative understanding of tumor evolution

$923,400
Raul Rabadan · Columbia University Health Sciences · R35 · FY2024 · CA

Characterizing germline and somatic alterations by glioma subtypes and clinical outcome

$923,381
Melissa L Bondy · Stanford University · R01 · FY2023 · CA

Therapeutic Targeting of Malignant Glioma Stem Cells

$923,113
Maciej S Lesniak · Northwestern University At Chicago · R35 · FY2016 · CA

Development of Small Molecule Inhibitors and Biologic Agents for Treatment of Glioblastoma Using Intracerebral Microdialysis and Signatures of Vulnerability

$920,861
Jana Portnow · Beckman Research Institute/City Of Hope · U19 · FY2022 · CA

Oncogenic mechanisms, molecular stratification and therapeutic targets of brain tumors

$920,732
Antonio Iavarone · University Of Miami School Of Medicine · R35 · FY2025 · CA

Microenvironmental regulation of glioblastoma radiosensitivity

$919,974
Philip Tofilon · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA

Oncolytic Polovirus, Immunotoxin, and Checkpoint Inhibitor Therapy of Gliomas

$919,541
Darell D Bigner · Duke University · R35 · FY2021 · CA

Liquid Biopsy in Glioblastoma Treated with Chemoradiation and an Oxygen Therapeutic

$919,366
Evan Charles Unger · Nuvox Pharma, Llc · R44 · FY2025 · CA

(PQB5)Molecular Wiring and Therapeutic Targeting of EGFR and PDGFR Signaling Netw

$918,872
Alain Charest · Beth Israel Deaconess Medical Center · R01 · FY2016 · CA

Development of Small Molecule Inhibitors and Biologic Agents for Treatment of Glioblastoma Using Intracerebral Microdialysis and Signatures of Vulnerability

$917,677
Jana Portnow · Beckman Research Institute/City Of Hope · U19 · FY2023 · CA

Therapeutic Targeting of Malignant Glioma Stem Cells

$916,993
Maciej S Lesniak · Northwestern University At Chicago · R35 · FY2020 · CA

Therapeutic Targeting of Malignant Glioma Stem Cells

$916,993
Maciej S Lesniak · Northwestern University At Chicago · R35 · FY2017 · CA

Therapeutic Targeting of Malignant Glioma Stem Cells

$916,993
Maciej S Lesniak · Northwestern University At Chicago · R35 · FY2021 · CA

Translational Development of Replication-Competent Retrovirus Vectors

$913,956
Noriyuki Kasahara · University Of California Los Angeles · U01 · FY2011 · NS

Oncolytic Polovirus, Immunotoxin, and Checkpoint Inhibitor Therapy of Gliomas

$912,796
Darell D Bigner · Duke University · R35 · FY2018 · CA

Motion Compensated Brain PET Imaging for Neuroscience Research

$911,987
David M Beylin · Brain Bio · R44 · FY2015 · DA

MT-125 for the Therapeutic Treatment of Glioblastoma

$911,407
Steven S Rosenfeld · Myosin Therapeutics Inc. · R42 · FY2025 · CA